


Healthcare News Roundup: Regulatory
HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
HSMN NewsFeed - 10 Jul 2013
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
HSMN NewsFeed - 8 Jul 2013
Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
Market Access Granted in Italy for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI(R) (pixantrone)
HSMN NewsFeed - 2 Jul 2013
ARIAD Announces Marketing Authorization for Iclusig(R) (ponatinib) in the European Union
ARIAD Announces Marketing Authorization for Iclusig(R) (ponatinib) in the European Union
HSMN NewsFeed - 28 Jun 2013
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
Genzyme Receives Positive CHMP Opinion for LEMTRADA(TM) (alemtuzumab) in Europe
HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
HSMN NewsFeed - 24 Jun 2013
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
XTANDI(TM) (Enzalutamide) Authorized in the European Union for Advanced Prostate Cancer
HSMN NewsFeed - 18 Jun 2013
Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval
Chembio's SURE CHECK(R) HIV 1/2 Assay for Rapid Point-of-Care Detection of HIV Receives CE Mark Approval
HSMN NewsFeed - 10 Jun 2013
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
HSMN NewsFeed - 5 Jun 2013
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
Echo Therapeutics Initiates CE Mark Clinical Trial of its Symphony(R) CGM System
HSMN NewsFeed - 29 May 2013
Teleflex Announces European Market Clearance for its Arrow(R) GPSCath(R) Balloon Dilatation Catheter
Teleflex Announces European Market Clearance for its Arrow(R) GPSCath(R) Balloon Dilatation Catheter
HSMN NewsFeed - 24 May 2013
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
PBAC Approves XIFAXAN(R) (Rifaxamin α) 550 mg Cost Effectiveness in Australia
HSMN NewsFeed - 23 May 2013
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
Astellas Receives Marketing Authorization for VESOMNI(TM) from the Netherlands Medicines Evaluation Board
